Celgene (CELG) Maintained Outperform at Oppenheimer, Defends Name
Tweet Send to a Friend
Oppenheimer maintains Outperform on Celgene (NASDAQ: CELG) price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


